Mucins TRIZ Cases
- Anti-MUC16 Antibodies Targeting Retained Glycosylated Epitopes
Targets the retained glycosylated MUC16 fraction instead of shed CA-125, enabling more reliable ovarian cancer binding and tumor inhibition.
Targets the retained glycosylated MUC16 fraction instead of shed CA-125, enabling more reliable ovarian cancer binding and tumor inhibition.